The HEAL Initiative is offering this grant to support pilot and preliminary research aimed at developing personalized approaches for polysubstance use prevention and treatment. This funding is crucial for laying the groundwork for future, larger-scale effectiveness trials. The grant seeks proposals focusing on early-stage developmental work that will inform full-scale clinical trials. Projects of interest include studies on innovative service delivery models and tailored treatment methods. Additionally, understanding practical implementation strategies for delivering complex treatment bundles is a key focus. This initiative intends to advance our understanding of effective interventions for polysubstance use, ensuring that future treatments are both personalized and widely implementable within healthcare settings.
Opportunity ID: 337157
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-22-048 |
Funding Opportunity Title: | HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 29, 2021 |
Last Updated Date: | Dec 29, 2021 |
Original Closing Date for Applications: | Mar 10, 2022 |
Current Closing Date for Applications: | Mar 10, 2022 |
Archive Date: | Apr 15, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $225,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Public and State controlled institutions of higher education Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities State governments City or township governments Native American tribal governments (Federally recognized) County governments For profit organizations other than small businesses Independent school districts |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this FOA is to encourage pilot and preliminary research in preparation for larger-scale services research effectiveness trials focused on personalized treatment and prevention services approaches to address polysubstance use. Research of interest includes, but is not limited to, developmental work toward future full-scale clinical trials to study service delivery and personalized, tailored treatment approaches, including understanding implementation approaches to support delivery of complex service bundles. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-048.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 337157 Full Announcement-RFA-DA-22-048 -> RFA-DA-22-048-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271127 | Feb 10, 2022 | Mar 10, 2022 | View |
Package 1
Mandatory forms
337157 RR_SF424_5_0-5.0.pdf
337157 PHS398_CoverPageSupplement_5_0-5.0.pdf
337157 RR_OtherProjectInfo_1_4-1.4.pdf
337157 PerformanceSite_4_0-4.0.pdf
337157 RR_KeyPersonExpanded_4_0-4.0.pdf
337157 PHS398_ResearchPlan_4_0-4.0.pdf
337157 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337157 RR_Budget_3_0-3.0.pdf
337157 RR_SubawardBudget30_3_0-3.0.pdf
337157 PHS398_ModularBudget_1_2-1.2.pdf
337157 PHS_AssignmentRequestForm_3_0-3.0.pdf